Overview

Oral Sedation During Cervical Dilator Placement

Status:
Completed

Trial end date:
2019-05-28

Target enrollment:

Participant gender:

Summary

This will be a randomized, double-blind, placebo-controlled trial involving 2 arms. It will be comparing the effects of placebo compared to 1 mg oral lorazepam/5 mg oral oxycodone on pain scores during cervical dilator placement prior to dilation and evacuation (D&E).

Phase:

Phase 4

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

Society of Family Planning

Treatments:

Lorazepam
Oxycodone